1. Molecular therapeutic strategies targeting pancreatic cancer induced cachexia
   Anastasiya Yakovenko et al, 2018, World Journal of Gastrointestinal Surgery CrossRef
2. Targeted Dual Intervention-Oriented Drug-Encapsulated (DIODE) Nanoformulations for Improved Treatment of Pancreatic Cancer
   Vijay Sagar Madamsetty et al, 2020, Cancers CrossRef
3. Combining Gemcitabine-Loaded Macrophage-like Nanoparticles and Erlotinib for Pancreatic Cancer Therapy
   Hongqiao Cai et al, 2021, Molecular Pharmaceutics CrossRef
4. The Role of Genetics and Synergistic Effect of Targeting Common Genetic Mutations in Acute Lymphoblastic Leukemia (ALL)
   Niloofar Pilehvari et al, 2023, Mini-Reviews in Medicinal Chemistry CrossRef
5. The anti-dysenteric drug fraxetin enhances anti-tumor efficacy of gemcitabine and suppresses pancreatic cancer development by antagonizing STAT3 activation
   Yangyang Guo et al, 2021, Aging CrossRef
6. JAK/STAT pathway: Extracellular signals, diseases, immunity, and therapeutic regimens
   Qian Hu et al, 2023, Frontiers in Bioengineering and Biotechnology CrossRef
7. Sodium cantharidinate, a novel anti-pancreatic cancer agent that activates functional p53
   Xiaoxiao Liu et al, 2021, Science China Life Sciences CrossRef